Tag Archives: Mel Spigelman

A Critical Path to New TB Treatments

Image via Wikipedia FDA Commissioner Margaret Hamburg announced, on Thursday, a new joint initiative between industry, FDA, and non-profit organizations designed to fast-track modern combination treatments for tuberculosis. Where once it took more than two decades to create new therapies for TB, this collaboration is expected to produce working treatments in less than six years, […]
Posted in R&D | Also tagged , , , , , , | 2 Comments
  • Categories

  • Meta